Gossamer Bio Inc
GOSS
Get informed when a big investor buys or sells
+ FollowMarket Cap$75.62M
Close$
$0.09
54.6% downside
Current Fair Value
54.6% downsideOvervalued by 54.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $75.62 Million |
|---|---|
| Enterprise Value | $73.58 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 2.01 |
| Outstanding Shares | 320,014,255 |
Return
| Return on Equity | 133.17% |
|---|---|
| Return on Assets | -162.91% |
| Return on Invested Capital | 347.21% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | 0.19 |
| Price to Sales | - |
| Price to Book Ratio | -0.19 |
| Enterprise Value to Revenue | 1.38 |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | -0.42 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$3.63 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$10.79 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1819▼ 14.36% |
|---|---|
| Total Calls | 2,843,300▼ 53.69% |
| Total Puts | 517,300▼ 74.12% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 71.34%▼ 9.61% |
|---|---|
| Total Invested | $55.40M▼ 90.34% |
| Investors Holding | 199▼ 18.00% |
ESG Score
No data
About Gossamer Bio Inc
CEO: Sheila Gujrathi